You are here

Article Text

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Migration of a Nexplanon contraceptive implant to the pulmonary artery
  1. Rachel Barlow-Evans1,
  2. Kulsum Jaffer1,
  3. Moji Balogun2
  1. 1 Sexual Health Services, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
  2. 2 Radiology, Birmingham Women's Hospital, Birmingham, UK
  1. Correspondence to Dr Rachel Barlow-Evans, rbarlowevans{at}doctors.org.uk

Summary

This is a case report of a 17-year-old woman who experienced distant intravascular migration of a radio-opaque Nexplanon contraceptive implant. She presented with an impalpable implant and this was located using CT in the left lower lobe pulmonary artery. Significant migration of a contraceptive implant is an uncommon risk. Using radio-opaque contraceptive implants such as Nexplanon increases the ability to locate them if migration occurs.

  • contraception drugs
  • obstetrics and gynaecology
  • sexual health
  • radiology

https://doi.org/10.1136/bcr-2017-219259

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors KJ identified the patient for case report write-up and acquired the necessary patient information.

      RB-E carried out the literature search, drafted the manuscript and obtained consent for publication from the patient.

      KJ proof-read and amended the manuscript and approved the final draft of the manuscript for submission.

      MB reported the original radiological images, prepared the images for inclusion and wrote the legends for the images.

    • Competing interests KJ received honoraria for delivering lectures and sponsored for attending various symposia by MSD. RB-E and MB have no competing interests to declare.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.